Avaleht › Rasvumine › Florida › Hialeah
Rasvumine kliinilised uuringud linnas Hialeah, FL
13 uuringut haiguse Rasvumine jaoks otsivad osalejaid linnas Hialeah ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
VärbamineFaas 2
- AGA Clinical Trials, Hialeah
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
VärbamineFaas 3
- Miguel Rebollar PA, Hialeah
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
VärbamineFaas 3
- Elite Cardiac Research Center LLC, Hialeah
- Elite Clinical Research, Hialeah
- Panax Clinical Research, Miami Lakes · 4 mi kaugusel
- ja veel 2
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
VärbamineFaas 2
- Indago Research & Health Center, Inc, Miami Lakes · 4 mi kaugusel
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
VärbamineFaas 3
- Elite Cardiac Research Center LLC, Hialeah
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
VärbamineFaas 2
- Indago Research & Health Center, Inc, Miami Lakes · 4 mi kaugusel
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
VärbamineFaas 4
- NeoClinical Research, Hialeah
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
VärbamineFaas 3
- Kailera Clinical Site, Miami Lakes · 4 mi kaugusel
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
VärbamineFaas 3
- Indago Research and Health Center, Miami Lakes · 4 mi kaugusel
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
VärbamineFaas 3
- San Marcus Research Clinic Inc, Miami Lakes · 4 mi kaugusel
- Indago Research and Health Center, Miami Lakes · 4 mi kaugusel
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
VärbamineFaas 3
- Aga Clinical Trials, Hialeah
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
VärbamineFaas 3
- Inpatient Research Clinic LLC, Miami Lakes · 4 mi kaugusel
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
VärbamineFaas 3
- Angels Clinical Research Institute, Miami Lakes · 4 mi kaugusel
Rasvumine uuringud teistes linnades
- Houston, TX43 uuringut
- Chicago, IL41 uuringut
- New York City, NY40 uuringut
- San Antonio, TX40 uuringut
- Washington, DC33 uuringut
- Orlando, FL31 uuringut
- Dallas, TX30 uuringut
- Boston, MA28 uuringut
- Las Vegas, NV27 uuringut
- Miami, FL27 uuringut
- Baltimore, MD25 uuringut
- Jacksonville, FL25 uuringut
Muud uuringud linnas Hialeah
- Skisofreenia13 uuringut
- Südamepuudulikkus12 uuringut
- 2. tüüpi diabeet10 uuringut
- Ülekaalulisus10 uuringut
- Steatoosne maksahaigus9 uuringut
- KOKH8 uuringut
- Suur depressiivne häire8 uuringut
- Ateroskleroos8 uuringut
- Alzheimeri tõbi6 uuringut
- Post-COVID seisundid (pikk COVID)6 uuringut
- Vähk (kõik liigid)6 uuringut
- Kardiovaskulaarsed haigused6 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.